Skip to main content
SpringerLink
Log in

Test the Urine: Understanding Haematuria, Proteinuria and Urinary Infection

  • Chapter
  • First Online:
Understanding Kidney Diseases

  • 980 Accesses

Abstract

In this chapter we explain:

  • How to interpret haematuria

  • How myoglobinuria causes acute kidney injury

  • The quantification of proteinuria

  • Nephrotic syndrome

  • How to diagnose urinary infection

  • How to treat urine infection in adults and children

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. National Collaborating Centre for Cancer. Suspected cancer: recognition and referral. NICE Guideline [NG12]. https://www.nice.org.uk/guidance/ng12/chapter/1-Recommendations-organised-by-site-of-cancer#urological-cancers.

  2. Collar JE, Ladva S, Cairns TDH, Cattell V. Red cell traverse through thin glomerular basement membranes. Kidney Int. 2001;59:2069–72. https://doi.org/10.1046/j.1523-1755.2001.00721.x. http://www.nature.com/ki/journal/v59/n6/full/4492253a.html#bib7.

    Article  CAS  PubMed  Google Scholar 

  3. Neal CR, Michel CC. Openings in frog microvascular endothelium induced by high intravascular pressures. J Physiol. 1996;492(1):39–52. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1158859/.

    Article  CAS  Google Scholar 

  4. Vivante A, Afek A, Frenkel-Nir Y, Tzur D, Farfel A, Golan E, Chaiter Y, Shohat T, Skorecki K, Calderon-Margalit R. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA. 2011;306(7):729–36. https://doi.org/10.1001/jama.2011.1141. http://jama.jamanetwork.com/article.aspx?articleid=1104231.

    Article  CAS  PubMed  Google Scholar 

  5. Rodrigues JC, Haas M, Reich HN. IgA nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677–86. https://doi.org/10.2215/CJN.07420716. https://cjasn.asnjournals.org/content/12/4/677.long.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93(3):700–5. https://doi.org/10.1016/j.kint.2017.10.019. Epub 2018 Jan 10. https://www.kidney-international.org/article/S0085-2538(17)30799-8/fulltext.

    Article  CAS  PubMed  Google Scholar 

  7. Rizk DV, Saha MK, Hall S, Novak L, Brown R, Huang Z-O, Fatima H, Julian BA, Novak J. Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1. JASN. 2019;30(10):2017–26. https://doi.org/10.1681/ASN.2018111156. Published ahead of print August 23, 2019. https://jasn.asnjournals.org/content/early/2019/08/22/ASN.2018111156.abstract.

    Article  CAS  PubMed  Google Scholar 

  8. Saha MK, Julian BA, Novak J, Rizk DV. Secondary IgA nephropathy. Kidney Int. 2018;94(4):674–81. https://doi.org/10.1016/j.kint.2018.02.030. Epub 2018 May 24. https://www.kidney-international.org/article/S0085-2538(18)30245-X/fulltext.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cassol CA, Bott C, Nadasdy GM, Alberton V, Malvar A, Nagaraja HN, Nadasdy T, Rovin BH, Satoskar AA. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy. Nephrol Dial Transplant. 2019; pii: gfz152. https://doi.org/10.1093/ndt/gfz152. https://www.academic.oup.com/ndt/advance-article-abstract/doi/10.1093/ndt/gfz152/5542608?redirectedFrom=fulltext.

  10. Le W, Liang S, Chen H, Wang S, Zhang W, Wang X, Wang J, Zeng C-H, Liu Z-H. Long-term outcome of IgA nephropathy patients with recurrent macroscopic hematuria. Am J Nephrol. 2014;40:43–50. http://www.karger.com/Article/Abstract/364954.

    Article  CAS  Google Scholar 

  11. Roberts IS. Oxford classification of immunoglobulin A nephropathy: an update. Curr Opin Nephrol Hypertens. 2013;22(3):281–6. https://doi.org/10.1097/MNH.0b013e32835fe65c. http://journals.lww.com/co-nephrolhypertens/Abstract/2013/05000/Oxford_classification_of_immunoglobulin_A.6.aspx.

    Article  CAS  PubMed  Google Scholar 

  12. Gutiérrez E, González E, Hernández E, Morales E, Martínez MA, Usera G, Praga M. Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol. 2007;2(1):51. http://cjasn.asnjournals.org/content/2/1/51.long.

    Article  Google Scholar 

  13. Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, Inoue K, Uehata T, Kaneko T, Okada N, Moriyama T, Horio M, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y. Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis. 2010;56(2):313. http://www.ajkd.org/article/S0272-6386(10)00682-7/abstract.

    Article  CAS  Google Scholar 

  14. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. JASN. 2000;11:1553–61. http://jasn.asnjournals.org/content/11/8/1553.full.

    CAS  PubMed  Google Scholar 

  15. Khitan ZJ, Glassock RJ. Foamy urine. CJASN. 2019;14(11):1664–6. https://doi.org/10.2215/CJN.06840619. https://cjasn.asnjournals.org/content/early/2019/09/30/CJN.06840619.

    Article  PubMed  Google Scholar 

  16. Stoycheff N, Stevens LA, Schmid CH, Tighiouart H, Lewis J, Atkins RC, Levey AS. Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition. Am J Kidney Dis. 2009;54(5):840–9. https://doi.org/10.1053/j.ajkd.2009.04.016. Epub 2009 Jun 25. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036614/.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Naresh CN, Hayen A, Weening A, Craig JC, Chadban SJ. Day-to-day variability in spot urine albumin-creatinine ratio. Am J Kidney Dis. 2013;62(6):1095–101. http://www.ajkd.org/article/S0272-6386(13)01007-X/abstract.

    Article  CAS  Google Scholar 

  18. Lambers Heerspink HJ, Kröpelin TF, Hoekman J, Zeeuw D, Reducing Albuminuria as Surrogate Endpoint (REASSURE) Consortium. Drug-induced reduction in albuminuria is associated with subsequent renoprotection: a meta-analysis. J Am Soc Nephrol. 2015;26(8):2055–64. https://doi.org/10.1681/ASN.2014070688. https://jasn.asnjournals.org/content/26/8/2055.long.

    Article  CAS  Google Scholar 

  19. Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, Leehey DJ, McCullough PA, O’Connor T, Palevsky PM, Reilly RF, Seliger SL, Warren SR, Watnick S, Peduzzi P, Guarino P, VA NEPHRON-D Investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013;369(20):1892–903. https://doi.org/10.1056/NEJMoa1303154. Epub 2013 Nov 9. http://www.nejm.org/doi/full/10.1056/NEJMoa1303154#t=articleTop.

    Article  CAS  PubMed  Google Scholar 

  20. MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis. 2006;48(1):8–20. http://www.ajkd.org/article/S0272-6386(06)00769-4/abstract.

    Article  CAS  Google Scholar 

  21. Barle H, Nyberg B, Essén P, Andersson K, McNurlan MA, Wernerman J, Garlick PJ. The synthesis rates of total liver protein and plasma albumin determined simultaneously in vivo in humans. Hepatology. 1997;25(1):154–8. http://onlinelibrary.wiley.com/doi/10.1002/hep.510250128/epdf.

    CAS  PubMed  Google Scholar 

  22. Bohnert BN, Menacher M, Janessa A, Wörn M, Schork A, Daiminger S, Kalbacher H, Häring HU, Daniel C, Amann K, Sure F, Bertog M, Haerteis S, Korbmacher C, Artunc F. Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome. Kidney Int. 2018;93(1):159–72. https://doi.org/10.1016/j.kint.2017.07.023. https://www.sciencedirect.com/science/article/abs/pii/S008525381730569016.

    Article  CAS  PubMed  Google Scholar 

  23. Hinrichs GR, Mortensen LA, Jensen BL, Bistrup C. Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report. Physiol Rep. 2018;6(12):e13743. https://doi.org/10.14814/phy2.13743. https://physoc.onlinelibrary.wiley.com/doi/full/10.14814/phy2.13743.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12(2):332–45. https://doi.org/10.2215/CJN.05000516. https://cjasn.asnjournals.org/content/12/2/332.long.

    Article  CAS  PubMed  Google Scholar 

  25. Hull RP, Goldsmith DJA. Nephrotic syndrome in adults. BMJ. 2008;336(7654):1185–9. www.ncbi.nlm.nih.gov/pmc/articles/PMC2394708/.

    Article  Google Scholar 

  26. Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018;94(5):861–9. https://doi.org/10.1016/j.kint.2018.04.024. Epub 2018 Jul 3. https://www.kidney-international.org/article/S0085-2538(18)30352-1/fulltext.

    Article  PubMed  Google Scholar 

  27. Loscalzo J. Venous thrombosis in the nephrotic syndrome. N Engl J Med. 2013;368:956–8. https://doi.org/10.1056/NEJMcibr1209459. http://www.nejm.org/doi/full/10.1056/NEJMcibr1209459.

    Article  CAS  PubMed  Google Scholar 

  28. Lee T, Biddle AK, Lionaki S, Derebail VK, Barbour SJ, Tannous S, Hladunewich MA, Hu Y, Poulton CJ, Mahoney SL, Jennette JC, Hogan SL, Falk RL, Cattran DC, Reich HN, Nachman PH. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney Int. 2014;85(6):1412–20. https://doi.org/10.1038/ki.2013.476. http://www.nature.com/ki/journal/v85/n6/full/ki2013476a.html.

    Article  CAS  PubMed  Google Scholar 

  29. Alwadhi RK, Mathew JL, Rath B. Clinical profile of children with nephrotic syndrome not on glucocorticoid therapy, but presenting with infection. J Paediatr Child Health. 2004;40(1–2):28–32. http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1754.2004.00285.x/abstract.

    Article  CAS  Google Scholar 

  30. St John A, Boyd JC, Lowes AJ, Price CP. The use of urinary dipstick tests to exclude urinary tract infection: a systematic review of the literature. Am J Clin Pathol. 2006;126(3):428–36. http://ajcp.ascpjournals.org/content/126/3/428.full.pdf.

    Article  Google Scholar 

  31. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, Stergachis A, Stamm WE. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335(7):468–74. http://www.nejm.org/doi/full/10.1056/NEJM199608153350703#t=articleTop.

    Article  CAS  Google Scholar 

  32. Moore EE, Hawes SE, Scholes D, Boyko EJ, Hughes JP, Fihn SD. Sexual intercourse and risk of symptomatic urinary tract infection in post-menopausal women. J Gen Intern Med. 2008;23(5):595–9. https://doi.org/10.1007/s11606-008-0535-y. Epub 2008 Feb 12. http://link.springer.com/article/10.1007%2Fs11606-008-0535-y.

    Article  PubMed  PubMed Central  Google Scholar 

  33. National Institute for Health and Care Excellence. Prostatitis—chronic. https://cks.nice.org.uk/prostatitis-chronic#!topicSummary.

  34. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10:CD001321. https://doi.org/10.1002/14651858.CD001321.pub5. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001321.pub5/full.

    Article  PubMed  Google Scholar 

  35. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adult. Clin Infect Dis. 2005;40(5):643–54. Epub 2005 Feb 4. http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Asymptomatic%20Bacteriuria.pdf.

    Article  Google Scholar 

  36. Swamy S, Kupelian AS, Khasriya R, Dharmasena D, Toteva H, Dehpour T, Collins L, Rohn JL, Malone-Lee J. Cross-over data supporting long-term antibiotic treatment in patients with painful lower urinary tract symptoms, pyuria and negative urinalysis. Int Urogynecol J. 2019;30(3):409–14. https://doi.org/10.1007/s00192-018-3846-5. Epub 2018 Dec 18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394536/.

    Article  PubMed  Google Scholar 

  37. Gharbi M, Drysdale JH, Lishman H, Goudie R, Molokhia M, Johnson AP, et al. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. BMJ. 2019;364:l525. https://doi.org/10.1136/bmj.l525.

    Article  PubMed  PubMed Central  Google Scholar 

  38. National Institute for Health and Care Excellence. Clinical guideline [CG54]. Urinary tract infection in under 16s: diagnosis and management. https://www.nice.org.uk/guidance/cg54.

  39. National Institute for Health and Care Excellence. NICE guideline [NG109]. Urinary tract infection (lower): antimicrobial prescribing. https://www.nice.org.uk/guidance/ng109.

  40. Birmingham Reflux Study Group. Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years’ observation. Br Med J (Clin Res Ed). 1987;295:237–41. http://www.bmj.com/content/295/6592/237.

    Article  Google Scholar 

  41. Hoberman A, Greenfield SP, Mattoo TK, et al. The RIVUR Trial Investigators. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370:2367–76. http://www.nejm.org/doi/full/10.1056/NEJMoa1401811#t=articleTop.

    Article  Google Scholar 

  42. Wang ZT, Wehbi E, Alam Y, Khoury A. A reanalysis of the RIVUR trial using a risk classification system. J Urol. 2018;199:1608–14. https://www.auajournals.org/doi/10.1016/j.juro.2017.11.080.

    Article  Google Scholar 

  43. Edwards D, Normand ICS, Prescod N, Smellie JM. Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children. Br Med J. 1977;2:285–8. http://www.bmj.com/content/2/6082/285.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Birmingham Heartlands Hospital, Birmingham, UK

    Hugh C. Rayner & Mark E. Thomas

  2. Birmingham Children’s Hospital, Birmingham, UK

    David V. Milford

Authors
  1. Hugh C. Rayner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark E. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David V. Milford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rayner, H.C., Thomas, M.E., Milford, D.V. (2020). Test the Urine: Understanding Haematuria, Proteinuria and Urinary Infection. In: Understanding Kidney Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-43027-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-43027-6_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-43026-9

  • Online ISBN: 978-3-030-43027-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation